| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | EVP, Pharm, R&D | Common Stock | 41.9K | $7.21M | $172.00 | Feb 15, 2022 | Direct |
| 10x Genomics, Inc. | Director | Class A Common Stock | 180K | $4.38M | $24.30 | Jun 11, 2024 | Direct |
| JOHNSON & JOHNSON | EVP, Pharm, R&D | Employee Stock Options (Right to Buy) | 38.7K | $2.81M | $72.54 | Feb 14, 2022 | Direct |
| JOHNSON & JOHNSON | EVP, Pharm, R&D | Restricted Share Units | 3.92K | $613K | $156.33 | Feb 14, 2022 | Direct |
| JOHNSON & JOHNSON | EVP, Pharm, R&D | Performance Share Units | 737 | $116K | $157.40 | Feb 15, 2022 | Direct |
| 10x Genomics, Inc. | Director | Stock Option (right to buy) | 4.66K | Jun 14, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TXG | 10x Genomics, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
| TXG | 10x Genomics, Inc. | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
| TXG | 10x Genomics, Inc. | May 11, 2023 | 3 | -$1.51M | 4 | May 15, 2023 | Director |
| TXG | 10x Genomics, Inc. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
| JNJ | JOHNSON & JOHNSON | Feb 14, 2022 | 5 | $5.87M | 4 | Feb 17, 2022 | EVP, Pharm, R&D |
| JNJ | JOHNSON & JOHNSON | Feb 14, 2022 | 3 | -$394K | 4 | Feb 15, 2022 | EVP, Pharm, R&D |
| JNJ | JOHNSON & JOHNSON | Jan 3, 2022 | 0 | $0 | 3 | Jan 13, 2022 | EVP, Pharm, R&D |
| TXG | 10x Genomics, Inc. | Jun 11, 2021 | 2 | $0 | 4 | Jun 15, 2021 | Director |